Global Constipation Market to Gain Momentum to 2021, Predicts Koncept Analytics in Its New Research Report Published at MarketPublishers.com
22 Sep 2017 • by Natalie Aster
LONDON – The USA is a key contributor to the world constipation market driven by a hike in the use of opioids amongst chronic disease patients and surging volumes of Rx drugs. The country’s market is expected to witness further growth with expanding ageing population and fast-paced development of novel drugs in the marketplace.
There are extensive opportunities for Rx drugs in the constipation market. Nevertheless, OTC drugs and laxatives are typically utilised for the treatment of constipation, patients and physicians have begun recognising the significance of branded drugs. The prospective market growth is based on ongoing growth of Rx therapies to treat constipation, increased R&D of novel drugs by biopharma companies, growing patient and physician awareness of efficient Rx alternatives to OTC medications.
Worldwide, the constipation market is poised to gain momentum in the offing, due to a hike in the prevalence rates of constipation, growing ageing population, an upsurge in health spending, a soaring number of spinal cord injury patients, growing expenditure on medicinal products and R&D expenditure in the pharma sector. Amid the major trends in the market comprise progressing drug products under pipeline and uptake of unhealthy lifestyles. Nevertheless, stiff regulations and lower awareness of Rx drugs could hinder the market growth.
New research report “Global Constipation Market: Industry Analysis & Outlook (2017-2021)” drawn up by Koncept Analytics offers an exhaustive research and granular analysis of the current market alongside providing the future outlook for the sector.
The study examines the market globally, with a focus on the USA, China, Japan, and Europe.
The study offers an all-round assessment of the key growth driving factors and challenges pertaining to the market, key trends and developments. The report canvasses the competitive scenario and includes granular profiles of the leading 3 players in the market.
Companies discussed include: Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., ARDELYX Inc., and Synergy Pharmaceuticals Inc.
To find many other new market research publications created by Koncept Analytics follow to the publisher’s page at MarketPubishers.com.